搜尋
AC Immune SA
ACIU添加自選
2.660USD
-0.170-6.01%
收盤 09-24 16:00（美東）
270.71M總市值
虧損本益比TTM
關於 AC Immune SA 公司
AC Immune SA is a Switzerland-based clinical-stage biopharmaceutical company. The Company focuses on precision medicine for neurodegenerative diseases. It designs, discovers and develops therapeutic, as well as diagnostic products for prevention, diagnosis and treatment of diseases caused by misfolding proteins. Its SupraAntigen and Morphomer technology platforms to create antibodies, small molecules and vaccines designed to address a broad range of neurodegenerative indications, such as Alzheimer's disease (AD). The Company's pipeline includes nine therapeutic product candidates with five in clinical trials, and three diagnostic candidates. Its lead product candidate is Crenezumab, a humanized and monoclonal anti-Abeta antibody for Alzheimer’s disease. It has collaborations with pharmaceutical companies, including Roche/Genentech, Eli Lilly, Biogen, Janssen Pharmaceuticals, Nestle Institute of Health Sciences, Life Molecular Imaging (formerly Piramal Imaging) and Essex Bio-Technology.
AC Immune SA 簡介
公司代碼ACIU
公司名稱AC Immune SA
上市日期Sep 23, 2016
CEOPfeifer (Andrea)
員工數量133
證券類型Ordinary Share
年結日Sep 23
公司地址EPFL Innovation Park
城市LAUSANNE
上市交易所NASDAQ OMX - NASDAQ BASIC
國家Switzerland
郵編1015
電話41213459121
網址https://www.acimmune.com/
公司代碼ACIU
上市日期Sep 23, 2016
CEOPfeifer (Andrea)
AC Immune SA公司高管
名稱
名稱/職務
職務
持股
持股變動
Prof. Dr. Andrea Pfeifer, Ph.D.
Prof. Dr. Andrea Pfeifer, Ph.D.
Chief Executive Officer, Co-Founder, Director
Chief Executive Officer, Co-Founder, Director
3.41M
-0.29%
Prof. Dr. Andrea Pfeifer, Ph.D.
Prof. Dr. Andrea Pfeifer, Ph.D.
Chief Executive Officer, Co-Founder, Director
Chief Executive Officer, Co-Founder, Director
3.41M
-0.29%
Prof. Dr. Andrea Pfeifer, Ph.D.
Prof. Dr. Andrea Pfeifer, Ph.D.
Chief Executive Officer, Co-Founder, Director
Chief Executive Officer, Co-Founder, Director
3.41M
-0.29%
Mr. Christopher Roberts
Mr. Christopher Roberts
Chief Financial Officer
Chief Financial Officer
75.37K
+49.52%
Mr. Christopher Roberts
Mr. Christopher Roberts
Chief Financial Officer
Chief Financial Officer
75.37K
+49.52%
Mr. Christopher Roberts
Mr. Christopher Roberts
Chief Financial Officer
Chief Financial Officer
75.37K
+49.52%
Prof. Carl June, M.D.
Prof. Carl June, M.D.
Non-Executive Independent Director
Non-Executive Independent Director
75.27K
+22.01%
Prof. Carl June, M.D.
Prof. Carl June, M.D.
Non-Executive Independent Director
Non-Executive Independent Director
75.27K
+22.01%
Prof. Carl June, M.D.
Prof. Carl June, M.D.
Non-Executive Independent Director
Non-Executive Independent Director
75.27K
+22.01%
Mr. Piergiorgio Donati
Mr. Piergiorgio Donati
Chief Technical Operations Officer
Chief Technical Operations Officer
74.24K
+38.31%
查看更多
名稱
名稱/職務
職務
持股
持股變動
Prof. Dr. Andrea Pfeifer, Ph.D.
Prof. Dr. Andrea Pfeifer, Ph.D.
Chief Executive Officer, Co-Founder, Director
Chief Executive Officer, Co-Founder, Director
3.41M
-0.29%
Prof. Dr. Andrea Pfeifer, Ph.D.
Prof. Dr. Andrea Pfeifer, Ph.D.
Chief Executive Officer, Co-Founder, Director
Chief Executive Officer, Co-Founder, Director
3.41M
-0.29%
Prof. Dr. Andrea Pfeifer, Ph.D.
Prof. Dr. Andrea Pfeifer, Ph.D.
Chief Executive Officer, Co-Founder, Director
Chief Executive Officer, Co-Founder, Director
3.41M
-0.29%
Mr. Christopher Roberts
Mr. Christopher Roberts
Chief Financial Officer
Chief Financial Officer
75.37K
+49.52%
Mr. Christopher Roberts
Mr. Christopher Roberts
Chief Financial Officer
Chief Financial Officer
75.37K
+49.52%
Mr. Christopher Roberts
Mr. Christopher Roberts
Chief Financial Officer
Chief Financial Officer
75.37K
+49.52%
常見問題
AC Immune SA的前五大股東是誰？
AC Immune SA的前五大股東如下：Prof. Dr. Andrea Pfeifer, Ph.D.
有多少機構持有AC Immune SA(ACIU)的股份？
截至2026Q1，共有106家機構持有AC Immune SA的股份，合計持有的股份價值約為26.78M，占公司總股份的26.32% 。與2025Q4相比，機構持股有所增加，增幅為-1698579.00。